FDA Drug Application (203109) for REVATIO by PFIZER

Back to FDA Applications sponsored by PFIZER

Application Number203109
Product Number001
FormFOR SUSPENSION;ORAL
DosageEQ 10MG BASE/ML
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameREVATIO
Active IngredientSILDENAFIL CITRATE

Active IngredientCount
List of drugs with Active Ingredient SILDENAFIL CITRATE3


Back to FDA Applications sponsored by PFIZER